IZAFE B.ST Stock Analysis
IZ
Uncovered
iZafe Group AB is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
iZafe Group AB is a medical technology company, which engages in the research, development, and marketing of medical and digital security solutions. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2011-04-04. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The firm operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. The company is active globally.